3）Nakata S, Murai J, Natsumeda M, Okada M, Takahashi H, Findlay TH, et al. Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin. Neuro Oncology 2023; 25(5): 899-912.4）Lafay-Cousin L, Dufour C. High-dose chemotherapy in children with newly diagnosed medulloblastoma. Cancers (Basel) 2022; 14(3): 837. 文 献361）Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Sposto R, et al. Phase Ⅲ study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006; 24(25): 4202-8. 2）Murai J. Targeting DNA repair and replication stress in the treatment of ovarian cancer. Int J Clin Oncol 2017; 22(4): 619-28.
元のページ ../index.html#50